TipRanks
Sumitomo Chemical India Ltd. (IN:SUMICHEM)
:SUMICHEM
India Market
Want to see IN:SUMICHEM full AI Analyst Report?

Sumitomo Chemical India Ltd. (SUMICHEM) AI Stock Analysis

7 Followers

Top Page

IN:SUMICHEM

Sumitomo Chemical India Ltd.

(SUMICHEM)

Select Model
Select Model
Select Model
Neutral 62 (OpenAI - Gpt-5.6Sol)
Rating:62Neutral
Price Target:
₹382.00
▼(-18.49% Downside)
Action:Downgraded
Date:10/04/26
The score is supported by strong financial quality (healthy margins, very low leverage, solid ROE), but is significantly pulled down by weak technical conditions (below major moving averages with negative MACD and very low RSI/Stoch) and an unattractive valuation profile (high P/E and low dividend yield).
Positive Factors
Strong and durable profitability
Consistently strong net and operating margins indicate that Sumitomo Chemical India has maintained meaningful profitability across the period shown. Sustained margin quality can support internal reinvestment, strengthen resilience through agricultural cycles, and provide a durable base for future earnings.
Negative Factors
Inconsistent revenue growth
Uneven revenue performance indicates that demand and pricing remain sensitive to the agricultural cycle. Repeated periods of contraction can make capacity planning and earnings forecasting more difficult, while limiting the consistency of the company’s longer-term growth trajectory.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong and durable profitability
Consistently strong net and operating margins indicate that Sumitomo Chemical India has maintained meaningful profitability across the period shown. Sustained margin quality can support internal reinvestment, strengthen resilience through agricultural cycles, and provide a durable base for future earnings.
Read all positive factors

Sumitomo Chemical India Ltd. (SUMICHEM) vs. iShares MSCI India ETF (INDA)

Sumitomo Chemical India Ltd. Business Overview & Revenue Model

Company Description
Sumitomo Chemical India Limited (SCIL) specializes in the global production and distribution of a diverse array of chemical products. Its core business encompasses the manufacture and sale of insecticides for household and public health use, agric...
How the Company Makes Money
SUMICHEM makes money primarily by selling crop protection products and related agricultural inputs. Revenue is generated from (1) sales of formulated/branded crop protection products (e.g., insecticides, herbicides, fungicides) marketed through ag...

Sumitomo Chemical India Ltd. Financial Statement Overview

Summary
Strong overall fundamentals: consistently solid profitability with net margins in the low-to-mid teens (peaking ~16–17% recently) and a very conservatively financed balance sheet (debt-to-equity ~1–2%) supporting strong ROE. Main offsets are revenue volatility (down years in 2024 and 2026) and uneven operating cash flow versus earnings, indicating working-capital-driven cash-flow swings.
Income Statement
78
Positive
Balance Sheet
92
Very Positive
Cash Flow
67
Positive
BreakdownMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue32.38B31.49B28.44B35.11B30.61B
Gross Profit10.21B12.70B10.49B12.24B11.36B
EBITDA8.02B6.32B4.75B6.67B6.01B
Net Income5.43B5.05B3.70B5.02B4.24B
Balance Sheet
Total Assets44.74B39.64B33.13B33.69B30.10B
Cash, Cash Equivalents and Short-Term Investments10.08B12.59B8.91B5.63B5.75B
Total Debt633.00M518.93M302.49M339.72M375.84M
Total Liabilities10.80B10.59B8.69B9.87B10.82B
Stockholders Equity33.90B29.01B24.42B23.82B19.27B
Cash Flow
Free Cash Flow4.78B4.87B6.93B2.70B1.08B
Operating Cash Flow5.22B5.17B7.57B3.89B2.22B
Investing Cash Flow-4.08B-4.57B-4.20B-3.27B-2.90B
Financing Cash Flow-828.79M-679.20M-3.37B-725.45M-626.38M

Sumitomo Chemical India Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price468.65
Price Trends
50DMA
464.58
Negative
100DMA
478.19
Negative
200DMA
452.17
Negative
Market Momentum
MACD
-26.35
Positive
RSI
14.46
Positive
STOCH
2.72
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SUMICHEM, the sentiment is Negative. The current price of 468.65 is above the 20-day moving average (MA) of 407.58, above the 50-day MA of 464.58, and above the 200-day MA of 452.17, indicating a bearish trend. The MACD of -26.35 indicates Positive momentum. The RSI at 14.46 is Positive, neither overbought nor oversold. The STOCH value of 2.72 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:SUMICHEM.

Sumitomo Chemical India Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
₹56.89B9.08―2.38%18.52%49.11%
68
Neutral
₹150.25B20.52―4.49%-2.78%23.56%
63
Neutral
₹37.40B19.07―1.56%6.82%11.93%
62
Neutral
₹177.02B30.52―0.37%-3.61%4.00%
58
Neutral
₹419.97B20.80―1.21%12.86%72.26%
56
Neutral
₹305.11B26.30―0.50%-16.57%-27.71%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:SUMICHEM
Sumitomo Chemical India Ltd.
354.65
-162.05
-31.36%
IN:BAYERCROP
Bayer Cropscience India Limited
3,343.15
-1,513.66
-31.17%
IN:PIIND
PI Industries Limited
2,011.00
-1,577.40
-43.96%
IN:RALLIS
Rallis India Limited
192.30
-69.45
-26.53%
IN:SHARDACROP
Sharda Cropchem Ltd.
630.55
-290.74
-31.56%
IN:UPL
UPL Limited
497.50
-175.54
-26.08%

Sumitomo Chemical India Ltd. Corporate Events

Sumitomo Chemical India Shares Q1 FY2026 Investor Presentation Highlighting Stability
Jul 27, 2026
Sumitomo Chemical India Ltd. has submitted an investor presentation detailing its financial results for the quarter ended June 30, 2026, to both BSE and the National Stock Exchange of India. The presentation, described as marking “a year of ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 04, 2026